Trial Profile
A retrospective cohort study of Liposomal doxorubicin and conventional doxorubicin in patients with de novo Diffuse Large B cell Lymphoma (DLBCL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2018
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Doxorubicin liposomal (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2018 New trial record
- 17 Jun 2018 Results evaluating liposomal doxorubicin and conventional formulation were presented at the 23rd Congress of the European Haematology Association.